A home run for human NaCT/SLC13A5/INDY: cryo-EM structure and homology model to predict transport mechanisms, inhibitor interactions and mutational defects.

The Biochemical Journal
Valeria Jaramillo-MartinezIna L Urbatsch

Abstract

NaCT (SLC13A5) is a Na+-coupled transporter for citrate, which is expressed in the liver, brain, testes, and bone. It is the mammalian homolog of Drosophila INDY, a cation-independent transporter for citrate, whose partial loss extends lifespan in the organism. In humans, loss-of-function mutations in NaCT cause a disease with severe neurological dysfunction, characterized by neonatal epilepsy and delayed brain development. In contrast with humans, deletion of NaCT in mice results in a beneficial metabolic phenotype with protection against diet-induced obesity and metabolic syndrome; the brain dysfunction is not readily noticeable. The disease-causing mutations are located in different regions of human NaCT protein, suggesting that different mutations might have different mechanisms for the loss of function. The beneficial effects of NaCT loss in the liver versus the detrimental effects of NaCT loss in the brain provide an opportunity to design high-affinity inhibitors for the transporter that do not cross the blood-brain barrier so that only the beneficial effects could be harnessed. To realize these goals, we need a detailed knowledge of the 3D structure of human NaCT. The recent report by Sauer et al. in Nature describing th...Continue Reading

References

Nov 26, 2002·Biochemical and Biophysical Research Communications·Katsuhisa InoueVadivel Ganapathy
Apr 13, 2006·The Biochemical Journal·Felix KnaufPeter S Aronson
Aug 25, 2009·Proteins·Srivatsan RamanDavid Baker
Sep 17, 2013·Structure·Yifan SongDavid Baker
Jul 6, 2014·American Journal of Human Genetics·Julien ThevenonJean-Baptiste Rivière
Jan 27, 2015·The Journal of Pharmacology and Experimental Therapeutics·Elangovan GopalVadivel Ganapathy
Apr 22, 2015·Nature Communications·Jani Reddy BollaEdward W Yu
Sep 20, 2015·Brain : a Journal of Neurology·Katia HardiesUNKNOWN autosomal recessive working group of the EuroEPINOMICS RES Consortium
Feb 2, 2016·Nature Structural & Molecular Biology·Christopher MulliganJoseph A Mindell
Mar 30, 2016·Annual Review of Biochemistry·David Drew, Olga Boudker
Apr 1, 2016·BMJ : British Medical Journal·Bradley S Quon, Steven M Rowe
Mar 8, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yangzom D BhutiaVadivel Ganapathy
Oct 11, 2017·Pharmacology & Therapeutics·Diana M WillmesAndreas L Birkenfeld
Nov 8, 2019·The New England Journal of Medicine·Peter G MiddletonUNKNOWN VX17-445-102 Study Group
Mar 11, 2020·The Journal of Biological Chemistry·Ahlam KhamaysiEhud Ohana
May 6, 2020·Biochemical Society Transactions·Alisa A Garaeva, Dirk J Slotboom

❮ Previous
Next ❯

Software Mentioned

Robetta

Related Concepts

Related Feeds

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.